Molecular characterization and antifungal susceptibility of the Candida parapsilosis species complex of clinical isolates from Monterrey, Mexico.

Medical mycology 20121001

Anidulafungin--challenges in development and validation of an LC-MS/MS bioanalytical method validated for regulated clinical studies.

Analytical and bioanalytical chemistry 20121001

Successful medical management of recalcitrant Fusarium solani keratitis: molecular identification and susceptibility patterns.

Mycopathologia 20120901

In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.

The Journal of antimicrobial chemotherapy 20120901

Anidulafungin--a new therapeutic option for Candida infections in liver transplantation.

Transplantation proceedings 20120901

Flash pulmonary oedema during anidulafungin administration.

Journal of clinical pharmacy and therapeutics 20120801

In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.

The Journal of antimicrobial chemotherapy 20120801

(1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120801

Isothermal microcalorimetry for antifungal susceptibility testing of Mucorales, Fusarium spp., and Scedosporium spp.

Diagnostic microbiology and infectious disease 20120801

Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.

Diagnostic microbiology and infectious disease 20120801

Elaboration of antibiofilm surfaces functionalized with antifungal-cyclodextrin inclusion complexes.

FEMS immunology and medical microbiology 20120701

Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20120701

Isothermal microcalorimetry: a novel method for real-time determination of antifungal susceptibility of Aspergillus species.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20120701

In vitro synergy testing of anidulafungin with fluconazole, tioconazole, 5-flucytosine and amphotericin B against some Candida spp.

Medicinal chemistry (Shariqah (United Arab Emirates)) 20120701

Some chronic rhinosinusitis patients have elevated populations of fungi in their sinuses.

The Laryngoscope 20120701

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20120701

Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20120601

Quantitative analysis of the antifungal drug anidulafungin by LC-online SPE-MS/MS in human plasma.

Biomedical chromatography : BMC 20120601

Safety of anidulafungin in solid organ transplant recipients.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20120601

Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: a combination study design in support of a Paediatric Investigation Plan.

Regulatory toxicology and pharmacology : RTP 20120601

In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.

Diagnostic microbiology and infectious disease 20120601

Convergent Evolution of Calcineurin Pathway Roles in Thermotolerance and Virulence in Candida glabrata.

G3 (Bethesda, Md.) 20120601

Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.

Mycoses 20120501

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.

The Journal of antimicrobial chemotherapy 20120501

Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp.

Diagnostic microbiology and infectious disease 20120501

The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.

Memorias do Instituto Oswaldo Cruz 20120501

[New apects in the diagnosis and therapy of dermatomycoses].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20120501

The role of micafungin and anidulafungin in the treatment of systemic fungal infections: applications and patents for two novel echinocandins.

Recent patents on anti-infective drug discovery 20120401

Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.

Mycopathologia 20120401

Comparison between a high-resolution single-stage Orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugs.

Rapid communications in mass spectrometry : RCM 20120315

Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii.

Mycoses 20120301

Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20120301

Systematic review of safety in paediatric drug trials published in 2007.

European journal of clinical pharmacology 20120201

Multiple subcutaneous cysts due to Exophiala spinifera in an immunocompetent patient.

Medical mycology 20120201

Comparison of anidulafungin's and fluconazole's in vivo activity in neutropenic and non-neutropenic models of invasive candidiasis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20120201

Epidemiology, risk factors and therapy of candidemia in pediatric hematological patients.

Pediatric reports 20120102

Poor compliance with antifungal drug use guidelines by transplant physicians: a framework for educational guidelines and an international consensus on patient safety.

Clinical transplantation 20120101

Anidulafungin: when and how? The clinician's view.

Mycoses 20120101

Protein Glycosylation in Aspergillus fumigatus Is Essential for Cell Wall Synthesis and Serves as a Promising Model of Multicellular Eukaryotic Development.

International journal of microbiology 20120101

Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms.

The Journal of antimicrobial chemotherapy 20120101

[Cost analysis of 3 candins in the treatment of invasive candidiasis in adult non-neutropaenic patients in Spain].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20120101

Candida biofilms and the host: models and new concepts for eradication.

International journal of microbiology 20120101

Antifungal resistance and new strategies to control fungal infections.

International journal of microbiology 20120101

Echinocandin use in the neonatal intensive care unit.

The Annals of pharmacotherapy 20120101

Candida spp. with acquired echinocandin resistance, France, 2004-2010.

Emerging infectious diseases 20120101

Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients.

Infection and drug resistance 20120101

Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination.

Mediterranean journal of hematology and infectious diseases 20120101

Chemosensitization as a means to augment commercial antifungal agents.

Frontiers in microbiology 20120101

Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis.

BMC microbiology 20120101

Rapid susceptibility testing and microcolony analysis of Candida spp. cultured and imaged on porous aluminum oxide.

PloS one 20120101

[Persistent candidemia in a renal-pancreatic transplant patient].

Revista iberoamericana de micologia 20120101

[Candida peritonitis in a haemodynamically stable patient. First choice of antifungal treatment … fluconazole?].

Revista iberoamericana de micologia 20120101

[Echinocandins in a critically ill patient during continuous venovenous renal replacement].

Revista iberoamericana de micologia 20120101

[Invasive candidiasis in a lung retransplantation recipient].

Revista iberoamericana de micologia 20120101

Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital.

PloS one 20120101

Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole.

PloS one 20120101

Microcolony imaging of Aspergillus fumigatus treated with echinocandins reveals both fungistatic and fungicidal activities.

PloS one 20120101

Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide.

Chemotherapy 20120101

Pharmacological assessment of the medicinal potential of Acacia mearnsii De Wild.: antimicrobial and toxicity activities.

International journal of molecular sciences 20120101

Inhibition of ion channels and heart beat in Drosophila by selective COX-2 inhibitor SC-791.

PloS one 20120101

β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.

PloS one 20120101

Advances in systemic antifungal therapy.

Clinics in dermatology 20120101

In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.

Diagnostic microbiology and infectious disease 20111201

Current role of echinocandins in the management of invasive aspergillosis.

Current infectious disease reports 20111201

Efg1 Controls caspofungin-induced cell aggregation of Candida albicans through the adhesin Als1.

Eukaryotic cell 20111201

Invasive candidiasis following liver transplantation and surgical complications.

Mycoses 20111201

Anidulafungin treatment in a kidney transplant recipient with hepatic damage.

Mycoses 20111201

Recurrent candidaemia and pacemaker wire infection with Candida albicans.

Mycoses 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

[Echinocandins].

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20111201

[Antifungal therapy update: new drugs and medical uses].

Enfermedades infecciosas y microbiologia clinica 20111201

Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20111101

Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist.

Medical mycology 20111101

Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation.

Mycoses 20111101

In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.

Antimicrobial agents and chemotherapy 20111101

EUCAST technical note on anidulafungin.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20111101

Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.

Clinical pharmacokinetics 20111101

New β-glucan inhibitors as antifungal drugs.

Expert opinion on therapeutic patents 20111001

Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.

The Journal of antimicrobial chemotherapy 20111001

Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo.

International journal of antimicrobial agents 20111001

Post-antifungal effects and time-kill studies of anidulafungin, caspofungin, and micafungin against Candida glabrata and Candida parapsilosis.

Diagnostic microbiology and infectious disease 20111001

Austrian clinical practice with anidulafungin in 2008: a multicenter survey.

Journal of chemotherapy (Florence, Italy) 20111001

Breakthrough fungemia due to Candida glabrata during posaconazole prophylaxis in hematology patients treated with anidulafungin - report of 5 cases.

Journal of chemotherapy (Florence, Italy) 20111001

[In vitro andulafungin susceptibility of 100 of Candida strains obtained previously to the introduction of this echinocandin in Chile].

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20111001

Fluconazole-, amphotericin-B-, caspofungin-, and anidulafungin-resistant Candida ciferrii: an unknown cause of systemic mycosis in a child.

Mycopathologia 20110901

In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.

Mycoses 20110901

Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin.

Journal of medical microbiology 20110901

Posaconazole: a new antifungal weapon.

Reviews on recent clinical trials 20110901

Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients.

PharmacoEconomics 20110801

Juvenile toxicity assessment of anidulafungin in rats: an example of navigating case-by-case study design through scientific and regulatory challenges.

Birth defects research. Part B, Developmental and reproductive toxicology 20110801

Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis.

The Journal of antimicrobial chemotherapy 20110801

Determination of micafungin and anidulafungin in human plasma: UV- or mass spectrometric quantification?

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110715

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).

International journal of antimicrobial agents 20110701

Echinocandins: addressing outstanding questions surrounding treatment of invasive fungal infections.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110701

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20110601

Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus.

The Journal of antimicrobial chemotherapy 20110601

Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro?

Clinical orthopaedics and related research 20110501

Isolation of Cryptococcus magnus and Cryptococcus chernovii from nasal cavities of pediatric patients with acute lymphoblastic leukemia.

Medical mycology 20110501

Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonates.

Clinical pharmacology and therapeutics 20110501

Development of an HPLC method for the determination of anidulafungin in human plasma and saline.

Journal of chromatographic science 20110501

[Echinocandins in children].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20110501

The value of amphotericin B in the treatment of invasive fungal infections.

Journal of critical care 20110401

In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods.

Medical mycology 20110401

Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.

Antimicrobial agents and chemotherapy 20110401

Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.

The Journal of antimicrobial chemotherapy 20110401

Current perspectives on echinocandin class drugs.

Future microbiology 20110401

Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.

Journal of chemotherapy (Florence, Italy) 20110401

Comparative in vitro susceptibility of clinical isolates of Candida paparsilosis complex and other Candida species to caspofungin and anidulafungin by Etest.

Journal of chemotherapy (Florence, Italy) 20110401

Characterization of Candida parapsilosis complex isolates.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110301

Additive antifungal activity of anidulafungin and human neutrophils against Candida parapsilosis biofilms.

The Journal of antimicrobial chemotherapy 20110301

Anidulafungin for the treatment of invasive candidiasis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110301

Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?

Expert review of anti-infective therapy 20110301

In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same?

Enfermedades infecciosas y microbiologia clinica 20110301

[Drug interactions in critically-ill patients. An important factor in the use of micafungin?].

Enfermedades infecciosas y microbiologia clinica 20110301

Current evidence of antifungal prophylaxis and therapy in pediatric patients.

Pediatric reports 20110224

[Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].

Pathologie-biologie 20110201

Echinocandin antifungal drugs in fungal infections: a comparison.

Drugs 20110101

Fusarium infection in lung transplant patients: report of 6 cases and review of the literature.

Medicine 20110101

Comparative genomics allowed the identification of drug targets against human fungal pathogens.

BMC genomics 20110101

Penicillium marneffei Infection in AIDS.

Pathology research international 20110101

Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures.

Therapeutics and clinical risk management 20110101

A Comprehensive review of abdominal infections.

World journal of emergency surgery : WJES 20110101

Treatment of candidemia in adult patients without neutropenia--an inconvenient truth.

Critical care (London, England) 20110101

Antifungal testing and high-throughput screening of compound library against Geomyces destructans, the etiologic agent of geomycosis (WNS) in bats.

PloS one 20110101

[Antifungal prophylaxis in HIV-seropositive liver transplant recipients].

Revista iberoamericana de micologia 20110101

Antimicrobial treatment of 'complicated' intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions.

European journal of medical research 20110101

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.

European journal of medical research 20110101

Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature.

European journal of medical research 20110101

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature.

European journal of medical research 20110101

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature.

European journal of medical research 20110101

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs: review of the literature.

European journal of medical research 20110101

Epidemiology and antifungal resistance in invasive candidiasis.

European journal of medical research 20110101

Pathogenesis and treatment of oral candidosis.

Journal of oral microbiology 20110101

Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients.

BMC infectious diseases 20110101

Epidemiology of invasive fungal infections in the mediterranean area.

Mediterranean journal of hematology and infectious diseases 20110101

Invasive Candida infections in patients with haematological malignancies and hematopoietic stem cell transplant recipients: current epidemiology and therapeutic options.

Mediterranean journal of hematology and infectious diseases 20110101

Five-years surveillance of invasive aspergillosis in a university hospital.

BMC infectious diseases 20110101

Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole.

Molecular systems biology 20110101

[Invasive candidiasis in liver transplant recipient: early rescue antifungal treatment].

Revista iberoamericana de micologia 20110101

Post-transplant aspergillosis and the role of combined neurosurgical and antifungal therapies under belatacept immunosuppression.

Surgical neurology international 20110101

Epidemiology and treatment approaches in management of invasive fungal infections.

Clinical epidemiology 20110101

Emerging fungal infections in immunocompromised patients.

F1000 medicine reports 20110101

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.

BMC infectious diseases 20110101

Efficacy and safety of current drug therapies for invasive aspergillosis.

Pharmacology 20110101

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis.

Critical care (London, England) 20110101

Candida colonization index in patients admitted to an ICU.

International journal of molecular sciences 20110101

Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal.

HIV/AIDS (Auckland, N.Z.) 20110101

[Susceptibility to antifungal agents of Candida sp. and biofilm formation].

Medycyna doswiadczalna i mikrobiologia 20110101

Radioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens.

Frontiers in microbiology 20110101

Spontaneous esophageal perforation in a patient with mixed connective tissue disease.

The open rheumatology journal 20110101

Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina.

Revista Argentina de microbiologia 20110101

Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin.

Antimicrobial agents and chemotherapy 20101201

Clinical experience of anidulafungin for the treatment of patients with documented candidemia.

Journal of chemotherapy (Florence, Italy) 20101201

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).

Diagnostic microbiology and infectious disease 20101101

Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis.

Medical mycology 20101101

Recent advances in the treatment of mucormycosis.

Current infectious disease reports 20101101

Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis.

The Journal of antimicrobial chemotherapy 20101001

Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.

Expert opinion on drug metabolism & toxicology 20101001

Role of echinocandins in the management of fungal infections in neonates.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 20101001

Screening for drug-resistant Candida yeasts with chromogenic agar.

Medical mycology 20100901

Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.

Medical mycology 20100901

Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis.

Medical mycology 20100801

[Anidulafungin: a new therapeutic option in systemic candidiasis].

Medecine et maladies infectieuses 20100801

Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.

International journal of antimicrobial agents 20100701

Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.

Antimicrobial agents and chemotherapy 20100701

Case report 4: Elderly patient with concomitant conditions.

Mycoses 20100701

Case report 5: Intensive care unit patient assessed using the Candida Score.

Mycoses 20100701

Case report 6: Candidaemia in a high risk liver transplant recipient.

Mycoses 20100701

Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.

The Journal of infectious diseases 20100615

[Therapy of candidemia and invasive candidiasis according to guidelines].

Mycoses 20100501

Traditional and emerging antifungal therapies.

Proceedings of the American Thoracic Society 20100501

In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.

Antimicrobial agents and chemotherapy 20100401

Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro.

International journal of antimicrobial agents 20100401

In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus.

Medical mycology 20100201

Fungal echinocandin resistance.

Fungal genetics and biology : FG & B 20100201

Fungicidal activity of anidulafungin in serum from patients does not correlate to its susceptible breakpoint against Candida spp.

The Journal of antimicrobial chemotherapy 20100201

Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence.

PLoS pathogens 20100201

Echinocandins: A ray of hope in antifungal drug therapy.

Indian journal of pharmacology 20100201

[Antifungal combination therapy in invasive fungal infections].

La Revue de medecine interne 20100101

Medical claims and current applications of the potent echinocandin antifungals.

Recent patents on anti-infective drug discovery 20100101

The echinocandins: three useful choices or three too many?

International journal of antimicrobial agents 20100101

A clinical review of echinocandins in pediatric patients.

The Annals of pharmacotherapy 20100101

Species distribution and susceptibility profile of Candida species in a Brazilian public tertiary hospital.

BMC research notes 20100101

Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection.

PloS one 20100101

A focus on intra-abdominal infections.

World journal of emergency surgery : WJES 20100101

Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence.

PloS one 20100101

A formal model for analyzing drug combination effects and its application in TNF-alpha-induced NFkappaB pathway.

BMC systems biology 20100101

Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites.

BMC microbiology 20100101

Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit.

Critical care (London, England) 20100101

Fungal echinocandin resistance.

F1000 biology reports 20100101

A rare case of toxic epidermal necrolysis with unexpected Fever resulting from dengue virus.

Case reports in dermatology 20100101

Current strategies for the prevention and management of central line-associated bloodstream infections.

Infection and drug resistance 20100101

Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection.

HIV/AIDS (Auckland, N.Z.) 20100101

Treatment of invasive candidiasis with echinocandins.

Mycoses 20091101

Neonatal peritoneal candidiasis successfully treated with anidulafungin add-on therapy.

The Annals of pharmacotherapy 20091101

Echinocandins: the newest class of antifungals.

The Annals of pharmacotherapy 20091001

Delivery of antifungal agents using bioactive and nonbioactive bone cements.

The Annals of pharmacotherapy 20091001

New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.

Expert review of anti-infective therapy 20091001

Extended daily dialysis does not affect the pharmacokinetics of anidulafungin.

International journal of antimicrobial agents 20090901

Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.

Expert opinion on investigational drugs 20090901

Anidulafungin is fungicidal and exerts a variety of postantifungal effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates.

Antimicrobial agents and chemotherapy 20090801

Echinocandins: pharmacokinetic and therapeutic issues.

Current medical research and opinion 20090701

Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.

PLoS pathogens 20090701

Lost in translation: differences in antimicrobial indication approval policies between the United States and Europe.

Clinical therapeutics 20090701

Overview of antifungal agents.

Clinics in chest medicine 20090601

Rapid Hemodynamic Deterioration and Death due to Acute Severe Refractory Septic Shock.

Journal of clinical medicine research 20090601

The changing face of epidemiology of invasive fungal disease in Europe.

Mycoses 20090501

[In vitro antifungal activity of micafungin].

Revista iberoamericana de micologia 20090331

[Micafungin: experimental therapy of fungal infections in animal models].

Revista iberoamericana de micologia 20090331

Antifungal activity of anidulafungin, a product of Aspergillus nidulans, against Aspergillus nidulans.

International journal of antimicrobial agents 20090301

In vitro and in vivo studies to characterize the clearance mechanism and potential cytochrome P450 interactions of anidulafungin.

Antimicrobial agents and chemotherapy 20090301

Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.

British journal of haematology 20090301

Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20090301

Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice.

Current medical research and opinion 20090201

Clinical indications for newer antifungal agents.

Journal of hospital medicine 20090201

Anidulafungin: new drug. Invasive candidiasis: just another echinocandin.

Prescrire international 20090201

Pharmacology and antifungal properties of anidulafungin, a new echinocandin.

Pharmacotherapy 20090101

Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis.

Annals of clinical microbiology and antimicrobials 20090101

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B.

Critical care (London, England) 20090101

Successful treatment of Candida parapsilosis and Pseudomonas aeruginosa infection using medical and surgical management in an injecting drug user with mitral and aortic valve endocarditis: a case report.

Journal of medical case reports 20090101

Recent advances in the management of invasive candidiasis: role of anidulafungin.

Drugs 20090101

Clinical aspects of invasive candidiasis: endocarditis and other localized infections.

Drugs 20090101

Invasive fungal infections: the challenge continues.

Drugs 20090101

Pharmacological properties of antifungal drugs with a focus on anidulafungin.

Drugs 20090101

Anidulafungin, a new echinocandin: in vitro activity.

Drugs 20090101

Anidulafungin, a new echinocandin: effectiveness and tolerability.

Drugs 20090101

Conclusions. Anidulafungin is a new echinocandin developed for more effective treatment of serious systemic fungal infections.

Drugs 20090101

Review of the pharmacology and clinical studies of micafungin.

Drug design, development and therapy 20090101

Anidulafungin and its role in candida infections.

Infection and drug resistance 20090101

Proposed quality control ranges for 2-microg anidulafungin disk diffusion testing and ability of the method to detect strains with elevated echinocandin MIC values.

Diagnostic microbiology and infectious disease 20081201

Anidulafungin: a novel echinocandin for candida infections.

Future microbiology 20081201

Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?

Therapeutics and clinical risk management 20081201

Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate.

Therapeutics and clinical risk management 20081201

[Current status of invasive fungal infections. New diagnostic techniques and antifungal agents].

Enfermedades infecciosas y microbiologia clinica 20081201

[In vitro activity of anidulafungin. Comparison with the activity of other echinocandins].

Enfermedades infecciosas y microbiologia clinica 20081201

[Pharmacokinetics and pharmacodynamics: interactions and adverse effects. Comparison with other echinocandins].

Enfermedades infecciosas y microbiologia clinica 20081201

[Current treatment of candidemia. Role of anidulafungin].

Enfermedades infecciosas y microbiologia clinica 20081201

[Role of anidulafungin in solid organ transplant recipients].

Enfermedades infecciosas y microbiologia clinica 20081201

[Role of anidulafungin in critically ill patients].

Enfermedades infecciosas y microbiologia clinica 20081201

[Potential of anidulafungin in hematological patients].

Enfermedades infecciosas y microbiologia clinica 20081201

[Potential of anidulafungin in combined therapy].

Enfermedades infecciosas y microbiologia clinica 20081201

A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus.

PLoS pathogens 20081101

Management of invasive Candida infections in non-neutropenic critically ill patients: from prophylaxis to early therapy.

International journal of antimicrobial agents 20081101

Anidulafungin in the treatment of patients with invasive candidiasis.

International journal of antimicrobial agents 20081101

Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.

Diagnostic microbiology and infectious disease 20081001

Significant differences in drug susceptibility among species in the Candida parapsilosis group.

Diagnostic microbiology and infectious disease 20080901

Anidulafungin: a drug evaluation of a new echinocandin.

Expert opinion on pharmacotherapy 20080901

Antifungal treatment strategies in high risk patients.

Mycoses 20080901

Treatment of invasive candidal infections: systematic review and meta-analysis.

Mayo Clinic proceedings 20080901

[What distinctions do Candida biofilms have to offer?].

Mycoses 20080901

In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.

Antimicrobial agents and chemotherapy 20080801

Update in infectious disease treatment.

Cleveland Clinic journal of medicine 20080801

Posaconazole in the management of refractory invasive fungal infections.

Therapeutics and clinical risk management 20080801

Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.

The Journal of infectious diseases 20080715

A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis.

Journal of acquired immune deficiency syndromes (1999) 20080701

[Echinocandins in invasive candidiasis].

Medizinische Klinik (Munich, Germany : 1983) 20080615

[Anidulafungin in the invasive fungal infection: current topics].